Sunday, January 23, 2022

The End of Big Pharma and Big Covid

Editor's note: It seems that what is happening in America is that the country is fragmenting from all these warring political and ideological factions. It is likely what will happen is that Americans will increasingly turn to tribal centers/groups out of self-preservation with natural medicine and alternative healing along with health clinics being organized and built to replace hospitals and the drug cartels. Trust between patients and their doctors and hospitals has been shattered and will likely never be recovered.
________

Source: Forbes

Moderna Stock Crash Intensifies: Losses Top $130 Billion

By Jonathan Ponciano | 21 Jan 2022
© SOPA Images/LightRocket via Getty Images - Moderna was last year’s third-best-performing stock in the S&P—now it's this year's worst.

Battered by a steep broad-market selloff this week, Moderna shares fell for a sixth straight day Friday as experts questioned whether Covid-19 vaccine sales alone will help justify the firm's meteoric valuation, intensifying a crash that's wiped out more than 60% of the value in one of last year's top stocks and turned it into this year's worst performer.

Moderna stock fell 4.4% Friday to an eight-month low of $160, pushing shares down more than 20% over the past week amid growing research suggesting Moderna's Covid-19 booster, while very effective against previous strains, has been less effective against the rapidly spreading omicron variant.

Though the number of Covid infections has spiked amid the omicron-spurred wave of the pandemic, the Centers for Disease Control and Prevention said Friday that Moderna and Pfizer boosters were 90% effective at preventing people infected with the new variant from being hospitalized.

Speaking to Yahoo Finance on Thursday, Jefferies analyst Michael Yee said the "overly high expectations" set last year, as Moderna's Covid-19 vaccine became widely available to the public, will "lead to challenges . . . as people digest" what's next for the firm beyond Covid vaccines.

Yee said the recent stock drawback has helped put Moderna's valuation in line with other biotechnology competitors, but he warned analysts increasingly expect Covid vaccine sales — currently Moderna's sole revenue source from a commercialized product — will fall over the next few years as the pandemic becomes endemic and competition heats up among treatment and prevention options.

Moderna's stock plunge has pulled prices down so much that Bank of America analyst Geoff Meacham told investors in a Friday note that its valuation is now "back to earth" after its meteoric rise during the pandemic.

Meacham said he's now focused on the company's pipeline beyond Covid (Moderna is also developing a flu vaccine), pointing to the firm's massive $17 billion in cash as a source of "strategic" opportunity.

In a Friday note, UBS analyst Eliana Merle was more optimistic about Moderna's prospects, calling its mRNA technology a disruptive force in the $35 billion annual vaccine market and saying its success with Covid-19 suggests a high likelihood of success for other vaccine targets.

Shares of Moderna have plunged 67% from an all-time closing high of $484 on August 9, wiping out about $133 billion from the firm's market capitalization, which now stands at roughly $65 billion.

Please go to Forbes to read more.
________


The technocratic power elite based around Silicon Valley and Newsom's handlers are moving aggressively to push Californians out of the state with overtly aggressive Covid injections, lockdowns, mandates, masks, taxes and business closures.   

California Lawmaker Introduces Bill To Allow Child Vaccinations Without Parental Consent


Related:

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Looking into our circumstances...